Clinical assessment and mechanisms of severe asthma including management of poor adherence to therapy and disease stratification to deliver personalised therapeutics in severe asthma. I lead the Medical Research Council UK Refractory Stratification Programme (RASP-UK ) which aims to deliver early ‘proof of concept' studies in stratified well phenotypes patients in severe asthma in partnership with the Industrial Partners. We also have programmes in use of routine health informatics and clinical registries and health economics.
Professor Heaney is open to wide-ranging PhD applications from candidates with a basic science or clinical background.
His fields of interest include;
Previous research experience is desirable although not essentialMake a PhD enquiry
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
Name: Pamela Jane McDowell
PhD title: Exacerbation profile in patients on mepolizumab for severe refractory eosinophilic asthma – an exploratory study
Years of Study: 1
Name: Luke Barry
PhD title: Steroid Induced Morbidity in Asthmatics: Costs and Consequences
Years of Study: 2
Name: Dr Diarmuid McNicholl PhD 2012
PhD title: The use of fractional exhaled nitric oxide (FeNO) and induced sputum in the identification of non-adherence in difficult to control asthma.
Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.The gateway to your postgraduate experience
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11